{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:50:04Z","timestamp":1793404204751,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.amjcard.2019.09.029","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T19:55:16Z","timestamp":1570823716000},"page":"120-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"125","author":[{"given":"Griffin","family":"Boll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan J.","family":"Rowin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Rastegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.09.029_bib0001","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Eng J Med"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0002","first-page":"e783","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0003","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0004","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0006","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0007","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0008","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1253\/circj.CJ-09-0140","article-title":"Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy. Results from Kochi RYOMA Study","volume":"73","author":"Kubo","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001002","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population","volume":"3","author":"Siontis","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21037\/cdt.2016.11.23","article-title":"Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis","volume":"7","author":"Masri","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0011","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.hjc.2017.01.027","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: a turning point towards increased morbidity and mortality","volume":"58","author":"Zegkos","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0012","first-page":"133","article-title":"Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation","volume":"37","author":"Doi","year":"2001","journal-title":"J Cardiol"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0013","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/heartjnl-2013-304908","article-title":"Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"100","author":"Azarbal","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0014","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ejhf.316","article-title":"Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HC Risk-CVA)","volume":"17","author":"Guttmann","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0016","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0017","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0140-6736(16)30968-0","article-title":"Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study","volume":"388","author":"Healey","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0018","doi-asserted-by":"crossref","first-page":"329","DOI":"10.21037\/acs.2017.07.03","article-title":"Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience","volume":"6","author":"Kotkar","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0019","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/CIRCULATIONAHA.107.691378","article-title":"Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"116","author":"Maron","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0020","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jtcvs.2015.07.063","article-title":"Symptom assessment and exercise impairment in surgical decision making in hypertrophic obstructive cardiomyopathy: relationship to outcomes","volume":"150","author":"Desai","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0021","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/01.CIR.0000162460.36735.71","article-title":"Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy","volume":"111","author":"Woo","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0022","doi-asserted-by":"crossref","first-page":"353","DOI":"10.21037\/acs.2017.07.07","article-title":"Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience","volume":"6","author":"Rastegar","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0023","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-5223(19)36685-1","article-title":"The surgical treatment of atrial fibrillation. IV. Surgical Technique","volume":"101","author":"Cox","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0024","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jtcvs.2010.02.027","article-title":"The longstanding, persistent confusion surrounding surgery for atrial fibrillation","volume":"139","author":"Cox","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jtcvs.2004.02.044","article-title":"A prospective, single center clinical trial of a modified Cox Maze procedure with bipolar radiofrequency ablation","volume":"128","author":"Gaynor","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0026","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jtcvs.2006.10.009","article-title":"The effect of ablation technology on surgical outcomes after the Cox-maze procedure: a propensity analysis","volume":"133","author":"Lall","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCULATIONAHA.111.074047","article-title":"Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial","volume":"125","author":"Boersma","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0028","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ejcts\/ezx017","article-title":"Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy","volume":"51","author":"Lapenna","year":"2017","journal-title":"Eur J Cardiothrac Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0029","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjcard.2003.10.025","article-title":"Effectiveness of atrial fibrillation surgery in patients with hypertophic cardiomyopathy","volume":"93","author":"Chen","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0030","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0003-4975(92)91404-W","article-title":"Combined maze procedure and septal myectomy in a septuagenarian","volume":"54","author":"Blitz","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0031","first-page":"323","article-title":"Combined cox max procedure, septal myectomy, and mitral valve replacement for severe hypertrophic obstructive cardiomyopathy complicated by chronic atrial fibrillation","volume":"9","author":"Matsui","year":"2003","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0032","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jtcvs.2017.08.063","article-title":"Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy","volume":"155","author":"Bogachev-Prokophiev","year":"2018","journal-title":"J Thorac Cardiovas Surg"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0033","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/euq013","article-title":"Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression","volume":"12","author":"Di Donna","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0034","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.amjcard.2017.02.040","article-title":"Occurrence and natural history of silent episodes of atrial fibrillation in hypertrophic cardiomyopathy","volume":"119","author":"Rowin","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0035","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.12.045","article-title":"Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance","volume":"113","author":"Maron","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.09.029_bib0036","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1161\/CIRCULATIONAHA.118.035484","article-title":"The case for earlier surgical myectomy in patients with obstructive hypertrophic cardiomyopathy","volume":"138","author":"Maron","year":"2018","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919310987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919310987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:31:22Z","timestamp":1757572282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919310987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0002914919310987"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.09.029","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}